6-166929583-GGGCATCAATGCTT-G
Position:
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The NM_003730.6(RNASET2):c.763_*4delAAGCATTGATGCC(p.Lys255fs) variant causes a frameshift, stop lost change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 33)
Consequence
RNASET2
NM_003730.6 frameshift, stop_lost
NM_003730.6 frameshift, stop_lost
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.68
Genes affected
RNASET2 (HGNC:21686): (ribonuclease T2) This ribonuclease gene is a novel member of the Rh/T2/S-glycoprotein class of extracellular ribonucleases. It is a single copy gene that maps to 6q27, a region associated with human malignancies and chromosomal rearrangement. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 10 ACMG points.
PVS1
Stoplost variant. No alternative stopcodon identified downstream, so we assume a Nonstop Mediated Decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RNASET2 | NM_003730.6 | c.763_*4delAAGCATTGATGCC | p.Lys255fs | frameshift_variant, stop_lost | 9/9 | ENST00000508775.6 | NP_003721.2 | |
RNASET2 | NM_003730.6 | c.764_*4delAAGCATTGATGCC | 3_prime_UTR_variant | 9/9 | ENST00000508775.6 | NP_003721.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RNASET2 | ENST00000508775.6 | c.763_*4delAAGCATTGATGCC | p.Lys255fs | frameshift_variant, stop_lost | 9/9 | 1 | NM_003730.6 | ENSP00000426455.2 | ||
RNASET2 | ENST00000508775 | c.764_*4delAAGCATTGATGCC | 3_prime_UTR_variant | 9/9 | 1 | NM_003730.6 | ENSP00000426455.2 | |||
ENSG00000249141 | ENST00000507747.1 | c.432+4495_432+4507delAAGCATTGATGCC | intron_variant | 5 | ENSP00000426906.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 02, 2021 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change results in a frameshift in the RNASET2 gene (p.Lys255Glnfs*). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 2 amino acid(s) of the RNASET2 protein and extend the protein by 20 additional amino acid residues. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with RNASET2-related conditions. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.